CHU Brugmann
Brussels, 1020, Belgium
NCT Number: NCT02394431
Sickle Cell Disease is a serious disease that is life-threatening for patients being homozygous for the SS form or heterozygous for the SC or βthal forms. The CHU Brugmann hospital currently regularly treats about 70 homozygous adult patients and this number is in constant augmentation.
Sickle cell disease patients may develop a cardiomyopathy due to chronic anemia, the haemosiderosis risk or, less frequently, to coronary vaso-occlusive damages.
The hypervolemia in patients with sickle cell disease causes an overestimation of the ejected left ventricular fraction measured by echocardiography, this parameter being very dependent of the blood volume.It has already been shown that the left ventricular ejection fraction was normal in most patients with sickle cell disease, but that its evaluation by parameters independent from the blood volume showed the existence of a dysfunction.
Myocardial strain, as measured by speckle tracking, is a echographic evaluation method of the cardiac function, independent of the blood volume. This technique hasn't been used much in sickle cell disease patients. A study using 3D speckle tracking on a limited number of sickle cell disease patients failed to show a strain anomaly. Moreover, the study highlighted a higher global longitudinal strain in this patient population. The investigators find these data hard to explain and in contradiction with previous studies using other cardiac function evaluation techniques, independent from the blood volume.
The primary goal of this study is thus
* to study the longitudinal strain by 2D echography * to determine if anomalies of the longitudinal strain exist in sickle cell disease patients with a normal ejected left ventricular fraction, compared to a control group of healthy patients.
The secondary goal of this study is to correlate, inside the sickle cell disease group, the possible strain anomalies with biological gravity parameters of the disease.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Brussels, 1020, Belgium
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Ejection fraction measured by Teicholz and planimetry, diastolic function, tissular doppler, myocardiac performance index, global longitudinal strain measured by speckle tracking, arterial pulmonary hypertension, left ventricular hypertrophy.
Hemoglobin levels, red cells, hematocrit, iron, ferritin
Blood transfusion number, severity of the sickle cell disease damage, evolution duration of the sickness
Time frame: once per year, at the annual medical visit planned according to the standart of care for this pathology
Ejection fraction measured by Teicholz and planimety.
Time frame: once per year, at the annual medical visit planned according to the standart of care for this pathology
Time frame: once per year, at the annual medical visit planned according to the standart of care for this pathology
Time frame: once per year, at the annual medical visit planned according to the standart of care for this pathology
Time frame: once per year, at the annual medical visit planned according to the standart of care for this pathology
Global longitudinal strain measured by speckle tracking.
Time frame: once per year, at the annual medical visit planned according to the standart of care for this pathology
Time frame: once per year, at the annual medical visit planned according to the standart of care for this pathology
Time frame: once per year, at the annual medical visit planned according to the standart of care for this pathology
Time frame: once per year, at the annual medical visit planned according to the standart of care for this pathology
Time frame: once per year, at the annual medical visit planned according to the standart of care for this pathology
Time frame: once per year, at the annual medical visit planned according to the standart of care for this pathology
Time frame: once per year, at the annual medical visit planned according to the standart of care for this pathology
Time frame: once per year, at the annual medical visit planned according to the standart of care for this pathology
Sickle cell disease organ damages.
Time frame: once per year, at the annual medical visit planned according to the standart of care for this pathology
Brugmann University Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05405114
Anemia, Anemia, Hemolytic
Mobile, Alabama, United States
View Trial DetailsNCT07721155
Anemia, Anemia, Hemolytic
Amsterdam, Netherlands
View Trial DetailsNCT03938324
Anemia, Anemia, Hemolytic
Durham, North Carolina, United States
View Trial DetailsNCT00011648
Anemia, Anemia, Hemolytic
Washington D.C., District of Columbia, United States
View Trial Details